Mode of action of dipyridamole on human platelets
Authors:
- L.C. BestLBL.C. Best
- M.B. McGuireMMM.B. McGuire
- P.B.B JonesPJP.B.B Jones
- T.K. HollandTHT.K. Holland
- T.J. MartinTMT.J. Martin
- F.E. PrestonFPF.E. Preston
- D.S. SegalDSD.S. Segal
- R.G.G. RussellR.G.G. Russell
- 1 January 1979
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 16 (3-4) , 367-379
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- DIPYRIDAMOLE AND PLATELET FUNCTIONThe Lancet, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- Antithrombotic DrugsDrugs, 1976
- Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet functionLife Sciences, 1975
- Cytochalasin B, the blood platelet release reaction and cyclic GMPNature, 1975
- Effects of dipyridamole and five related agents on human platelet aggregation and adenosine uptakeThrombosis Research, 1973
- CYCLIC 3′,5′‐ADENOSINE MONOPHOSPHATE IN HUMAN BLOOD PLATELETS IV. REGULATORY ROLE OF CYCLIC AMP IN PLATELET FUNCTION*Annals of the New York Academy of Sciences, 1972
- Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugsBiochimica et Biophysica Acta (BBA) - General Subjects, 1972
- Interactions of Dipyridamole and Adenosine on Platelet AggregationNature, 1969